Nitric oxide (NO) represents a potential wound therapeutic agent due to its ability to regulate
inflammation and eradicate bacterial infections. Two broad strategies exist to utilize NO for …

Inhaled nitric oxide (iNO) was first used in neonatal practice in 1992 and has subsequently
been used extensively in the management of neonates and children with cardiorespiratory …

Background Pulmonary hypertensive crises (PHTC) are a major cause of morbidity and
mortality after congenital heart surgery. Inhaled nitric oxide is frequently used as rescue …

Especially written for qualified nurses working in intensive care units, this comprehensive
text has been developed to be as accessible as possible. This fourth edition has been …

Previous studies have raised the possibility that the measurement of nitric oxide (NO.)
concentrations in expired air may represent a noninvasive measure of lower airway …

Objective. To determine the clinical role of inhaled nitric oxide (iNO) in the treatment of
persistent pulmonary hypertension of the newborn (PPHN). Study Design. Prospective open …

This article briefly reviews the background of endothelium-dependent vasorelaxation,
describes the nitric oxide/cGMP/protein kinase pathway and its role in modulating …

Hypoxic vasoconstriction is unique to pulmonary circulation. The pulmonary response is part
of a self-regulatory mechanism by which pulmonary capillary blood flow is automatically …

Inhaled low-dose nitric oxide (2, 10, 20 ppm), together with high inspired oxygen
concentration (0.80), was administered after corrective operations 13 times to 10 infants …

Eleven newborns admitted consecutively to the neonatal unit with respiratory failure and
severe persistent pulmonary hypertension (PPHN) were included in a clinical trial to assess …